Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Research Bridge Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
Research Bridge Partners

Research Bridge Partners

Operating

Non-profit Research Bridge Partners boosts societal and economic returns by bridging university innovators with national commercialization resources.

Location
Austin, TX, US
Founded
2016
Firm
Compare
Portfolio
Employees
Website

Research Bridge Partners is a non-profit investment firm focused on enhancing the societal and economic returns of research universities in mid-continent regions by bridging innovators with national commercialization resources. The firm primarily invests in biomedical startups emerging from these universities, typically engaging in seed funding rounds. Their investments are program-related, sourced from other charities to further their tax-exempt educational and scientific purposes.

Notable portfolio companies include Asalyxa Bio and UT Southwestern Medical Center, with significant investments of $2 million and $4 million, respectively. Founded by Isaac Barchas and Reid Hoffman, Research Bridge Partners emphasizes creating high-quality investment opportunities in regions with limited commercialization resources. The firm offers unique value-add services by leveraging its deep connections with national commercialization networks to support the growth and success of its portfolio companies.

Research Bridge Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments3
Current Portfolio Count3
Total Portfolio Exits0

Top Investment Stages

Seed2 (66.7%)
Grant1 (33.3%)

Stage Mix

Seed 67%Grant 33%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Tetricus Labs logo

Tetricus Labs

UT Southwestern Medical Center logo

UT Southwestern Medical Center

Asalyxa Bio logo

Asalyxa Bio

Research Bridge Partners - Similar Investment Firms

Beta Bridge Capital logo

Beta Bridge Capital

b2cap.com

Uniseed logo

Uniseed

uniseed.com

Middle Bridge Partners logo

Middle Bridge Partners

Fairbridge Park logo

Fairbridge Park

fairbridgepark.com

ResearchHub logo

ResearchHub

researchhub.com

Bridge Investments logo

Bridge Investments

Bridge Angel Investors logo

Bridge Angel Investors

Bridge Growth Partners logo

Bridge Growth Partners

Partners Investment logo

Partners Investment

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

BioCrossroads logo

BioCrossroads

biocrossroads.com

Bridgeport Partners logo

Bridgeport Partners

bgptpartners.com

Emerging Innovations Fund logo

Emerging Innovations Fund

otc-prf.org

BioImpact Capital logo

BioImpact Capital

Founders Bridge logo

Founders Bridge

foundersbridge.net

Research Bridge Partners - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 610000Educational Services
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 611000Educational Services
  • 541700Scientific Research and Development Services
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 8200Educational Services
  • 6720Investment Offices
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 6722Management Investment Offices, Open-end